Tunnicliffe Jonathan
Insider CIK 1597990 · RVNC Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-05-07 | 2015-05-15 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-05-07 | 2015-05-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-04-08 | 2014-04-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 398,717 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 1,539,343 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 500,039 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 658,551 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 658,551 | — | $0 | 2,697,933 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 398,717 | — | $0 | 3,096,650 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 2,039,382 | — | $0 | 2,039,382 | SEC↗ |